NCT04271085 (iLIVE) is a clinical trial of Observational study in Terminal Care, sponsored by Erasmus Medical Center.

Who is sponsoring NCT04271085?

NCT04271085 is sponsored by Erasmus Medical Center.

What drugs are being tested in NCT04271085?

Interventions in NCT04271085: Observational study.

What condition does NCT04271085 study?

NCT04271085 studies Terminal Care.

Is NCT04271085 still recruiting?

NCT04271085 is currently completed. Last updated 11 March 2025.

Last reviewed 2025-03-11 · How we verify

NCT04271085: iLIVE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Living Well, Dying Well. a Research Programme to Support Living Until the End

Completed Last updated 11 March 2025

What this trial tests

trial testing Observational study in Terminal Care in 1,500 participants. Completed in 31 July 2023.

Timeline

1 September 2020

Primary endpoint
31 July 2023

31 July 2023

Quick facts

Lead sponsor	Erasmus Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,500
Start date	1 September 2020
Primary completion	31 July 2023
Estimated completion	31 July 2023
Sites	11 locations across New Zealand, Netherlands, Sweden, United Kingdom, Germany, Norway, Argentina, Slovenia

Drugs / interventions tested

Observational study — full drug profile →

Conditions studied

Terminal Care — all drugs for Terminal Care →

Sponsor

Erasmus Medical Center

Who can join

18 and older, any sex, with Terminal Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The iLIVE project involves a cohort study in which patients with an estimated life expectancy of six months or less are followed until they die. In total, the investigators will include 2200 patients in 11 countries, i.e. 200 per country. The primary outcome for the cohort study is a descriptive assessment of the concerns, expectations and preferences around dying and end-of-life care of patients and their relatives, in different settings and cultures..

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

'Someone must do it': multiple views on family's role in end-of-life care - an international qualitative study.
Tripodoro VA, Veloso VI, Víbora Martín E, Kodba-Čeh H, et al · · 2024 · cited 8× · PMID 39099623 · DOI 10.1177/26323524241260425
Live well, die well – an international cohort study on experiences, concerns and preferences of patients in the last phase of life: the research protocol of the iLIVE study
Yildiz B, Allan S, Bakan M, Barnestein-Fonseca P, et al · · 2022

Verify or expand the search:

Other trials of Observational study

Trials testing the same drug.

NCT07255443 — Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital · not yet recruiting
NCT07343713 — Correlation Between the Degree of Middle Ear Pressure and the Eustachian Tube Dimensions : Radiological Study · not yet recruiting
NCT07192991 — Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America · not yet recruiting
NCT07219927 — Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: · recruiting
NCT06244238 — A Study on the Relationship Between Job Satisfaction and Retention Intentions of Emergency Room Nurses · unknown

Other recruiting trials for Terminal Care

Currently open trials in the same condition.

NCT07505706 — Patient Journey in Palliative Care Within the NOVO Hospital Group. · active not recruiting
NCT07512505 — Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor · recruiting

Other Erasmus Medical Center trials

Trials by the same sponsor.

NCT07406269 — Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery · NA · not yet recruiting
NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
NCT07383194 — Prediction Models for LDLT Outcomes · not yet recruiting
NCT07426575 — Evaluating the Usability of New Dialysis Bags · not yet recruiting
NCT07329296 — The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04271085 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erasmus Medical Center
Last refreshed: 11 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04271085.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing